Behavioral Therapy Development for Methamphetamine Abusers
Phase 2
Withdrawn
- Conditions
- The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings
- Registration Number
- NCT00249678
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
The purpose of this study is...to assess whether placing a substance abuse intervention for HIV+ methamphetamine users within an HIV medical care setting improves rates of follow-up on referral to treatment by primary care physicians; reduces drug use and sexual risk behaviors more than treatment-as-usual; and increases rates of adherence to HIV medication regimens.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
- HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the UCLA CARE clinic, aged 18-65
- Willing to give informed consent and comply with study procedures;
- Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications;
- Diagnosed with current methamphetamine abuse as determined by MINI; and
- Interested in seeking treatment for their methamphetamine abuse and in participating in this research project.
Exclusion Criteria
- Unwilling to give, or withdrawal of, informed consent;
- Inability to understand nature of study;
- A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria for current bipolar disorder or a psychotic disorder);
- Current suicidal ideation or suicide attempt within the past 3 months; and
- Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.
- Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Medication compliance Craving Addiction severity Psychiatric interview Sex-risk behavior
- Secondary Outcome Measures
Name Time Method Depression Quality of Life
Trial Locations
- Locations (3)
UCLA Medical Center
🇺🇸Los Angeles, California, United States
UCLA, Integrated Substance Abuse Programs
🇺🇸Los Angeles, California, United States
UCLA CARE Clinic
🇺🇸Los Angeles, California, United States
UCLA Medical Center🇺🇸Los Angeles, California, United States